Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epigenomic and Transcriptomic Profiling of Solitary Fibrous Tumors Identifies Site-Specific Patterns and Candidate Genes Regulated by DNA Methylation.
Beird HC, Cloutier JM, Gokgoz N, Eeles C, Griffin AM, Ingram DR, Wani KM, Segura RL, Cohen L, Ho C, Wunder JS, Andrulis IL, Futreal PA, Haibe-Kains B, Lazar AJ, Wang WL, Przybyl J, Demicco EG. Beird HC, et al. Lab Invest. 2024 Nov;104(11):102146. doi: 10.1016/j.labinv.2024.102146. Epub 2024 Sep 30. Lab Invest. 2024. PMID: 39357799
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.
Nakazawa MS, Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel SR, Conley AP, Roland CL, Soliman PT, Beird HC, Wu CC, Ingram DR, Lazcano R, Song D, Wani KM, Lazar AJ, Yap TA, Wang WL, Livingston JA. Nakazawa MS, et al. Among authors: beird hc. Mol Cancer Ther. 2024 Jul 2;23(7):1057-1065. doi: 10.1158/1535-7163.MCT-23-0761. Mol Cancer Ther. 2024. PMID: 38561019 Free PMC article.
Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.
Beird HC, Wu CC, Nakazawa M, Ingram D, Daniele JR, Lazcano R, Little L, Davies C, Daw NC, Wani K, Wang WL, Song X, Gumbs C, Zhang J, Rubin B, Conley A, Flanagan AM, Lazar AJ, Futreal PA. Beird HC, et al. HGG Adv. 2023 Jul 19;4(4):100224. doi: 10.1016/j.xhgg.2023.100224. eCollection 2023 Oct 12. HGG Adv. 2023. PMID: 37593416 Free PMC article.
Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.
Noh S, Bertini C, Mira-Avendano I, Kaous M, Patel B, Faiz SA, Shannon VR, Balachandran DD, Bashoura L, Adachi R, Evans SE, Dickey B, Wu C, Shroff GS, Manzano JG, Granwehr B, Holloway S, Dickson K, Mohammed A, Muthu M, Song H; D3CODE Team; Chung C, Wu J, Lee L, Jiang Y, Khawaja F, Sheshadri A. Noh S, et al. Cancer Med. 2023 Sep;12(17):17753-17765. doi: 10.1002/cam4.6396. Epub 2023 Aug 18. Cancer Med. 2023. PMID: 37592894 Free PMC article.
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W. Fang H, et al. Among authors: beird hc. Leukemia. 2023 Sep;37(9):1919-1921. doi: 10.1038/s41375-023-01956-3. Epub 2023 Jul 13. Leukemia. 2023. PMID: 37443196 No abstract available.
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors.
Khlebus E, Vuttaradhi VK, Welte T, Khurana N, Celestino J, Beird HC, Gumbs C, Little L, Legarreta AF, Fellman BM, Nguyen T, Lawson B, Ferri-Borgogno S, Mok SC, Broaddus RR, Gershenson DM, Futreal PA, Hillman RT. Khlebus E, et al. Among authors: beird hc. Mol Cancer Res. 2023 May 1;21(5):483-494. doi: 10.1158/1541-7786.MCR-22-0623. Mol Cancer Res. 2023. PMID: 37068116 Free PMC article.
32 results